These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 32981460)
1. Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3. Virdi RS; Bavisotto RV; Hopper NC; Vuksanovic N; Melkonian TR; Silvaggi NR; Frick DN SLAS Discov; 2020 Dec; 25(10):1162-1170. PubMed ID: 32981460 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Drug-like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3. Virdi RS; Bavisotto RV; Hopper NC; Vuksanovic N; Melkonian TR; Silvaggi NR; Frick DN bioRxiv; 2020 Sep; ():. PubMed ID: 32676591 [TBL] [Abstract][Full Text] [Related]
3. High-Throughput Screening and Quantum Mechanics for Identifying Potent Inhibitors Against Mac1 Domain of SARS-CoV-2 Nsp3. Selvaraj C; Dinesh DC; Panwar U; Boura E; Singh SK IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1262-1270. PubMed ID: 33306471 [TBL] [Abstract][Full Text] [Related]
4. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors. Brosey CA; Houl JH; Katsonis P; Balapiti-Modarage LPF; Bommagani S; Arvai A; Moiani D; Bacolla A; Link T; Warden LS; Lichtarge O; Jones DE; Ahmed Z; Tainer JA Prog Biophys Mol Biol; 2021 Aug; 163():171-186. PubMed ID: 33636189 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment. Jung LS; Gund TM; Narayan M Protein J; 2020 Dec; 39(6):619-630. PubMed ID: 33185784 [TBL] [Abstract][Full Text] [Related]
6. Xie S; Cao S; Wu J; Xie Z; Liu YT; Fu W; Zhao Q; Liu L; Yang L; Li J J Biomol Struct Dyn; 2024 Jul; 42(10):5229-5237. PubMed ID: 37349935 [TBL] [Abstract][Full Text] [Related]
7. The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase. Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR J Virol; 2021 Jan; 95(3):. PubMed ID: 33158944 [TBL] [Abstract][Full Text] [Related]
8. Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening. Roy A; Alhammad YM; McDonald P; Johnson DK; Zhuo J; Wazir S; Ferraris D; Lehtiö L; Leung AKL; Fehr AR Antiviral Res; 2022 Jul; 203():105344. PubMed ID: 35598780 [TBL] [Abstract][Full Text] [Related]
9. Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors. Yazdani B; Sirous H; Brogi S; Calderone V Viruses; 2023 Nov; 15(12):. PubMed ID: 38140532 [TBL] [Abstract][Full Text] [Related]
10. Molecular Basis for ADP-Ribose Binding to the Mac1 Domain of SARS-CoV-2 nsp3. Frick DN; Virdi RS; Vuksanovic N; Dahal N; Silvaggi NR Biochemistry; 2020 Jul; 59(28):2608-2615. PubMed ID: 32578982 [TBL] [Abstract][Full Text] [Related]